Discovery of novel inhibitors of human galactokinase by virtual screening

Journal of Computer-aided Molecular Design
Xin HuMin Shen

Abstract

Classic Galactosemia is a potentially lethal autosomal recessive metabolic disorder caused by deficient galactose-1-phosphate uridyltransferase (GALT) that results in the buildup of galactose-1-phosphate (gal-1-p) in cells. Galactokinase (GALK1) is the enzyme responsible for converting galactose into gal-1-p. A pharmacological inhibitor of GALK1 is hypothesized to be therapeutic strategy for treating galactosemia by reducing production of gal-1-p. In this study, we report the discovery of novel series of GALK1 inhibitors by structure-based virtual screening (VS). Followed by an extensive structural modeling and binding mode analysis of the active compounds identified from quantitative high-throughput screen (qHTS), we developed an efficient pharmacophore-based VS approach and applied for a large-scale in silico database screening. Out of 230,000 compounds virtually screened, 350 compounds were cherry-picked based on multi-factor prioritization procedure, and 75 representing a diversity of chemotypes exhibited inhibitory activity in GALK1 biochemical assay. Furthermore, a phenylsulfonamide series with excellent in vitro ADME properties was selected for downstream characterization and demonstrated its ability to lower gal-1-p in ...Continue Reading

References

Jan 1, 1995·European Journal of Pediatrics·R Gitzelmann
May 9, 2000·Biochemical and Biophysical Research Communications·K Lai, L J Elsas
Nov 5, 2004·Cellular and Molecular Life Sciences : CMLS·H M HoldenR J Reece
Dec 14, 2004·The Journal of Biological Chemistry·James B ThodenHazel M Holden
Aug 10, 2005·Pediatric Neurology·Keith R RidelDonald L Gilbert
Sep 29, 2006·Journal of Medicinal Chemistry·Gregory L WarrenMartha S Head
May 21, 2008·Journal of Biomolecular Screening·Klaas J WierengaManshu Tang
Sep 10, 2008·Chemistry Central Journal·Xiaohui JiangJaques Reifman
Apr 17, 2009·RNA·P Therese LangIrwin D Kuntz
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Feb 4, 2011·Journal of Inherited Metabolic Disease·Julia B HennermannJeannette Klein
Feb 18, 2011·Journal of Chemical Information and Modeling·Mark McGann
Oct 25, 2011·Molecular Genetics and Metabolism·M TangK Lai
Nov 30, 2011·ACS Medicinal Chemistry Letters·Si OdejinmiK Lai
Mar 23, 2013·European Journal of Medicinal Chemistry·Federica ChiapporiAnna Marabotti
Jul 30, 2014·Future Medicinal Chemistry·Kent LaiAnna Marabotti
Jan 3, 2015·Bioorganic & Medicinal Chemistry Letters·Li LiuMatthew B Boxer
Mar 11, 2015·World Journal of Pediatrics : WJP·Francesco PortaMarco Spada
Jul 9, 2013·Journal of Chemical Theory and Computation·Daniel R Roe, Thomas E Cheatham
Feb 7, 2017·Journal of Chemical Information and Modeling·Stephen J CapuzziAlexander Tropsha

❮ Previous
Next ❯

Citations

Apr 22, 2020·Pharmaceutical Patent Analyst·David J Timson
Feb 3, 2021·Journal of Personalized Medicine·Britt DelnoyMaria Estela Rubio-Gozalbo
Jun 18, 2021·ACS Pharmacology & Translational Science·Xin HuMin Shen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.